29Sep 2024
Recombinant BNP Effective in Elderly Heart Failure Treatment

Recombinant BNP Effective in Elderly Heart Failure Treatment

A retrospective case-control study found that recombinant human brain natriuretic peptide (rhBNP) significantly improved clinical outcomes in elderly patients with heart failure. Posttreatment BNP levels were notably lower in the group receiving rhBNP compared to the control group (p < 0.05). Furthermore, improvements in cardiac parameters such as left ventricular and atrial diameters, left ventricular shortening fraction, and cardiac output were observed, with statistically significant differences favoring the rhBNP group (p < 0.05). The clinical efficacy rate was also higher in the rhBNP-treated patients. This suggests that rhBNP may offer a superior therapeutic option for heart failure in elderly patients, improving both BNP levels and overall cardiac function.

  • #cardiology

Like

Save

Share